MedPath

Pharmacokinetic-Pharmacodynamic Modelling of Sevoflurane

Not Applicable
Conditions
Pharmacokinetics and pharmacodynamics of sevoflurane
Anaesthesiology - Anaesthetics
Registration Number
ACTRN12612001296820
Lead Sponsor
Auckland City Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Adults undergoing surgery requiring general anaesthesia and use of a volatile anaesthetic
- Surgery expected to last at least one hour

Exclusion Criteria

- Unable to consent
- Surgery often associated with blood loss mandating blood transfusion, pregnant
- Unable to monitor bispectral index

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Arterial concentration of sevoflurane[Before the start of general anaesthesia, at 2 minute, 4 minutes, 8 minute, 16 minute, 32 minute then every 15~30 minute. The interval after 32nd minutes of anaesthesia will be determined by the clinical situations and recommendation of attending doctors. If they prefer to monitor arterial pressure reading at the particular moment, we will hold off taking arterial samples as arterial pressure can not be read briefly while arterial sample is being taken. As by 32nd minute the sevoflurane concentration in endtidal and arterial sample should be stablised, taking samples at either 15 minute interval or 30 min interval should not vary too much.<br>All the outcomes will be measured as long patient is anaesthetised.];End-tidal concentrations of sevoflurane[This will be measured continuously using anaesthetic machine];Bispectral monitoring data[This will be measured continuously using BIS monitoring]
Secondary Outcome Measures
NameTimeMethod
Blood pressure[It will be measured continuously using arterial line until the end of anaesthesia. This is a routine anaesthetic practice.]
© Copyright 2025. All Rights Reserved by MedPath